| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4299212
Max Phase: Preclinical
Molecular Formula: C26H45N11O6S2
Molecular Weight: 570.66
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCN(CC)CC.Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNS(=O)(=O)NC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)[C@@H](O)[C@H]1N
Standard InChI: InChI=1S/C20H30N10O6S2.C6H15N/c21-13-16(32)10(36-19(13)30-8-25-15-17(22)23-7-24-18(15)30)5-26-38(34,35)29-12(31)4-2-1-3-11-14-9(6-37-11)27-20(33)28-14;1-4-7(5-2)6-3/h7-11,13-14,16,19,26,32H,1-6,21H2,(H,29,31)(H2,22,23,24)(H2,27,28,33);4-6H2,1-3H3/t9-,10+,11-,13+,14-,16+,19+;/m0./s1
Standard InChI Key: NVCFATWBAAQDQA-XCWKCCEMSA-N
Associated Targets(non-human)
Biotin--acetyl-CoA-carboxylase ligase 26 Activities
Mycobacterium tuberculosis 203094 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 570.66 | Molecular Weight (Monoisotopic): 570.1791 | AlogP: -2.33 | #Rotatable Bonds: 10 |
| Polar Surface Area: 241.50 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 7 |
| #RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
| CX Acidic pKa: 4.14 | CX Basic pKa: 8.63 | CX LogP: -3.80 | CX LogD: -3.80 |
| Aromatic Rings: 2 | Heavy Atoms: 38 | QED Weighted: 0.12 | Np Likeness Score: 0.01 |
References
| 1. Bockman MR, Kalinda AS, Petrelli R, De la Mora-Rey T, Tiwari D, Liu F, Dawadi S, Nandakumar M, Rhee KY, Schnappinger D, Finzel BC, Aldrich CC.. (2015) Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors., 58 (18): [PMID:26299766] [10.1021/acs.jmedchem.5b00719] |
Source
Source(1):